AlphaStar Capital Management LLC Acquires New Holdings in Humana Inc. $HUM

AlphaStar Capital Management LLC acquired a new stake in shares of Humana Inc. (NYSE:HUMFree Report) during the second quarter, HoldingsChannel reports. The firm acquired 1,255 shares of the insurance provider’s stock, valued at approximately $307,000.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Vanguard Group Inc. raised its stake in shares of Humana by 8.9% during the first quarter. Vanguard Group Inc. now owns 13,972,872 shares of the insurance provider’s stock valued at $3,697,222,000 after purchasing an additional 1,143,662 shares in the last quarter. Dodge & Cox raised its stake in shares of Humana by 5.5% during the first quarter. Dodge & Cox now owns 10,755,215 shares of the insurance provider’s stock valued at $2,845,830,000 after purchasing an additional 557,175 shares in the last quarter. Pzena Investment Management LLC raised its stake in shares of Humana by 6.5% during the second quarter. Pzena Investment Management LLC now owns 4,076,667 shares of the insurance provider’s stock valued at $996,664,000 after purchasing an additional 247,744 shares in the last quarter. Davis Selected Advisers raised its stake in shares of Humana by 3.3% during the first quarter. Davis Selected Advisers now owns 2,331,343 shares of the insurance provider’s stock valued at $616,873,000 after purchasing an additional 74,434 shares in the last quarter. Finally, Hotchkis & Wiley Capital Management LLC raised its stake in shares of Humana by 1.6% during the first quarter. Hotchkis & Wiley Capital Management LLC now owns 1,236,936 shares of the insurance provider’s stock valued at $327,293,000 after purchasing an additional 19,613 shares in the last quarter. 92.38% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages recently weighed in on HUM. Robert W. Baird cut their price objective on shares of Humana from $300.00 to $297.00 and set a “neutral” rating on the stock in a research note on Friday, July 25th. Wolfe Research lifted their target price on Humana from $283.00 to $313.00 and gave the stock an “outperform” rating in a report on Monday, October 6th. Evercore ISI started coverage on Humana in a report on Monday, September 22nd. They set an “in-line” rating and a $295.00 target price on the stock. Truist Financial set a $300.00 target price on Humana in a report on Tuesday, October 14th. Finally, Piper Sandler lowered their target price on Humana from $288.00 to $272.00 and set a “neutral” rating on the stock in a report on Thursday, July 31st. Eight investment analysts have rated the stock with a Buy rating, ten have issued a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, Humana presently has a consensus rating of “Hold” and a consensus target price of $297.58.

Check Out Our Latest Stock Report on Humana

Humana Trading Down 2.7%

Shares of HUM opened at $278.02 on Friday. The business’s 50-day moving average price is $281.34 and its 200 day moving average price is $258.81. The stock has a market capitalization of $33.44 billion, a P/E ratio of 21.34, a P/E/G ratio of 1.71 and a beta of 0.42. Humana Inc. has a 1-year low of $206.87 and a 1-year high of $315.35. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.69.

Humana (NYSE:HUMGet Free Report) last issued its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share for the quarter, missing analysts’ consensus estimates of $6.32 by ($0.05). The company had revenue of $32.39 billion during the quarter, compared to analysts’ expectations of $31.85 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%.The company’s revenue for the quarter was up 9.6% compared to the same quarter last year. During the same period in the prior year, the business posted $6.96 EPS. Analysts expect that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Friday, December 26th will be paid a $0.885 dividend. The ex-dividend date of this dividend is Friday, December 26th. This represents a $3.54 dividend on an annualized basis and a yield of 1.3%. Humana’s dividend payout ratio (DPR) is currently 27.17%.

About Humana

(Free Report)

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Featured Articles

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUMFree Report).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.